- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Patients Recieving Anti-PD-1 or Anti-PD-L1 Immunotherapies in Ireland
Total 1 results
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Germany, Thailand, France, Belgium, China, Argentina, Greece, Turkey, Malaysia, Portugal, Hungary, Brazil, United States, India